Cereno Scientific AB (publ) (STO:CRNO.B)

Cereno Scientific AB Income Statement

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	80.9	49.28	57.54	44.81	8.22
Revenue	80.9	49.28	57.54	44.81	8.22
Revenue Growth (YoY)	64.18%	-14.36%	28.42%	444.85%	18.64%
Gross Profit	80.9	49.28	57.54	44.81	8.22
Selling, General & Admin	154.5	89.9	84.12	59.57	23.95
Other Operating Expenses	1.96	3.6	-	-	-
Operating Expenses	156.74	93.51	84.13	59.59	23.97
Operating Income	-75.84	-44.24	-26.6	-14.78	-15.75
Interest Expense	-26.09	-5.3	-0.46	-1.25	-0.27
Interest & Investment Income	2.4	1.84	0.31	0	-
Currency Exchange Gain (Loss)	-	-0.41	-0.9	-0.23	-
Pretax Income	-99.53	-48.11	-27.65	-16.25	-16.02
Income Tax Expense	-	-	0.01	0	0
Net Income	-99.53	-48.11	-27.65	-16.25	-16.02
Net Income to Common	-99.53	-48.11	-27.65	-16.25	-16.02
Shares Outstanding (Basic)	282	234	138	105	73
Shares Outstanding (Diluted)	282	234	138	105	73
Shares Change (YoY)	20.50%	70.00%	30.64%	44.58%	397.03%
EPS (Basic)	-0.35	-0.21	-0.20	-0.15	-0.22
EPS (Diluted)	-0.35	-0.21	-0.20	-0.15	-0.22
Free Cash Flow	-107.29	-36.92	-18.62	-13.14	-16.15
Free Cash Flow Per Share	-0.38	-0.16	-0.14	-0.13	-0.22
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	-93.74%	-89.78%	-46.22%	-32.99%	-191.47%
Profit Margin	-123.02%	-97.63%	-48.06%	-36.28%	-194.78%
Free Cash Flow Margin	-132.62%	-74.91%	-32.35%	-29.32%	-196.40%
EBITDA	-75.55	-44.22	-26.58	-14.77	-15.73
EBITDA Margin	-93.38%	-89.75%	-46.20%	-32.96%	-191.30%
D&A For EBITDA	0.29	0.01	0.01	0.01	0.01
EBIT	-75.84	-44.24	-26.6	-14.78	-15.75
EBIT Margin	-93.74%	-89.78%	-46.22%	-32.99%	-191.47%
Revenue as Reported	80.9	49.28	57.54	44.81	8.22

Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.